Clinical Trials
30
Active:0
Completed:12
Trial Phases
5 Phases
Phase 1:1
Phase 2:2
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Not Applicable
13 (59.1%)Phase 4
5 (22.7%)Phase 2
2 (9.1%)Phase 1
1 (4.5%)Phase 3
1 (4.5%)Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
Recruiting
- Conditions
- ESCCRadiomicsLymph Node Metastasis
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 500
- Registration Number
- NCT07050576
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Clinical Trial on the Accuracy of Blood Pressure Measurement by YE990 Medical Automatic Electronic Sphygmomanometer
Not yet recruiting
- Conditions
- Blood Pressure
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-22
- Target Recruit Count
- 85
- Registration Number
- NCT06565702
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University Hospital, Hefei, Anhui, China
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-04-09
- Target Recruit Count
- 50
- Registration Number
- NCT06355843
- Locations
- 🇨🇳
First affiliated hospital of anhui university, Hefei, Anhui, China
Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy
Completed
- Conditions
- Renal Cell CarcinomaRobotic Surgical Procedures
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-19
- Target Recruit Count
- 15
- Registration Number
- NCT06317207
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
Not Applicable
Suspended
- Conditions
- Malignant TumorsPositron-Emission Tomography
- Interventions
- Drug: 68Ga-Fibroblast activation protein inhibitor
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-02-21
- Target Recruit Count
- 60
- Registration Number
- NCT06270394
- Locations
- 🇨🇳
FirstHAnhuiMU, Hefei, Anhui, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found